The invention relates generally to an-tibodies that bind CD166, activatable antibodies that specifically bind to CD 166 and methods of making and using these anti-CD166 antibodies and an-ti-CD166 activatable antibodies in a variety of thera-peutic, diagnostic and prophylactic indications.